Nutra Pharma Corp. (NPHC) Receives Regulatory Approval to Market Nyloxin in India
8/10/2011 10:34:29 AM
CORAL SPRINGS, Fla.--(BUSINESS WIRE)--Nutra Pharma Corporation (OTCBB:NPHC), a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain, announced today that it has received approval in India for its Nyloxin™ line of pain relievers. Following the approval, Nutra Pharma has accepted orders for the products through their distributor, Nutritional Alliance, for export to India-based importers.
comments powered by